|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2003-9-4
|
|
pubmed:abstractText |
Capecitabine and oxaliplatin are both active anticancer agents in the treatment of patients with advanced colorectal cancer. The aim of this phase II study is to determine the efficacy and tolerability of combining oxaliplatin with capecitabine in the treatment of advanced non-pretreated colorectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1378-82
|
|
pubmed:dateRevised |
2009-11-3
|
|
pubmed:meshHeading |
pubmed-meshheading:12954576-Adult,
pubmed-meshheading:12954576-Aged,
pubmed-meshheading:12954576-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12954576-Colorectal Neoplasms,
pubmed-meshheading:12954576-Deoxycytidine,
pubmed-meshheading:12954576-Dose-Response Relationship, Drug,
pubmed-meshheading:12954576-Female,
pubmed-meshheading:12954576-Fluorouracil,
pubmed-meshheading:12954576-Follow-Up Studies,
pubmed-meshheading:12954576-Humans,
pubmed-meshheading:12954576-Male,
pubmed-meshheading:12954576-Middle Aged,
pubmed-meshheading:12954576-Organoplatinum Compounds
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer.
|
|
pubmed:affiliation |
Department of Medical Oncology A, Regina Elena Cancer Institute, Roma, Italy. massimozeuli@tin.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
